KC
EW icon

Kingfisher Capital’s Edwards Lifesciences EW Stock Holding History

Kingfisher Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-19,842
Closed -$1.25M – 145
2020
Q1 		$1.25M Sell
19,842
-3,252
-14% -$235K 0.64% 60
2019
Q4 		$1.8M Sell
23,094
-81
-0.3% -$6.33K 0.84% 36
2019
Q3 		$1.7M Sell
23,175
-180
-0.8% -$12.6K 1.01% 33
2019
Q2 		$1.44M Buy
23,355
+93
+0.4% +$5.62K 0.89% 44
2019
Q1 		$1.48M Sell
23,262
-57
-0.2% -$3.25K 0.95% 40
2018
Q4 		$1.19M Sell
23,319
-3
-0% -$152 0.85% 43
2018
Q3 		$1.35M Buy
23,322
+453
+2% +$22.2K 0.73% 45
2018
Q2 		$1.11M Sell
22,869
-1,653
-7% -$77.2K 0.7% 55
2018
Q1 		$1.14M Buy
24,522
+21
+0.1% +$912 0.73% 57
2017
Q4 		$921K Sell
24,501
-147
-0.6% -$5.39K 0.59% 68
2017
Q3 		$898K Sell
24,648
-714
-3% -$27.2K 0.6% 67
2017
Q2 		$1M Buy
25,362
+477
+2% +$17.4K 0.68% 64
2017
Q1 		$780K Buy
24,885
+7,689
+45% +$241K 0.56% 71
2016
Q4 		$537K Buy
+17,196
New +$557K 0.4% 87

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Kingfisher Capital's EW Position: Q2 2020 in Review

Kingfisher Capital sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 19,842 shares — an estimated $1.25M sold.

Kingfisher Capital first reported a position in EW in Q4 2016 and held it in 14 quarters. The position peaked at $1.8M in Q4 2019. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Kingfisher Capital reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Kingfisher Capital sold 19,842 Edwards Lifesciences shares in Q2 2020, an estimated $1.25M.
  • Kingfisher Capital first reported a position in Edwards Lifesciences in Q4 2016 and held it in 14 quarters.
  • Kingfisher Capital's Edwards Lifesciences position peaked at $1.8M in Q4 2019.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Kingfisher Capital's 13F filing for Q2 2020, filed 11 Aug 2020.